Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects

scientific article published on September 1, 1995

Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.15.9.1280
P8608Fatcat IDrelease_t6x3nx6ew5a73kgq7h6g7c3czm
P953full work available at URLhttps://www.ahajournals.org/doi/full/10.1161/01.ATV.15.9.1280
P698PubMed publication ID7670939

P50authorMarkku LaaksoQ28050161
P2093author name stringJ. Kuusisto
Y. A. Kesäniemi
K. Kervinen
L. Mykkänen
P2860cites workGene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset familiesQ27860677
Biochemical JournalQ864221
Apolipoprotein E: cholesterol transport protein with expanding role in cell biologyQ28294791
Polymorphism of apolipoprotein EQ29030664
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's diseaseQ29614952
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein EQ29615236
Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985.Q31007028
Cholesterol and mortality. 30 years of follow-up from the Framingham studyQ34183820
Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 yearsQ34312337
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer diseaseQ34662682
Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall studyQ35180405
Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetesQ35181442
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based studyQ36888014
Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery diseaseQ43514952
Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?Q43890386
Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probesQ44605230
Polymorphism at the apoprotein-E locus in relation to risk of coronary diseaseQ44706046
Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effectsQ44826850
Smoking and coronary heart disease mortality in the elderlyQ46186010
Apolipoprotein E polymorphism and Alzheimer's disease.Q53316388
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.Q53316390
Apolipoprotein epsilon 4 homozygosity in young men with coronary heart diseaseQ67521913
Apolipoprotein E phenotyping: a word of cautionQ67831801
Asymptomatic hyperglycemia and cardiovascular risk factors in the elderlyQ67973780
Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart diseaseQ68053157
Apolipoprotein E polymorphism and atherosclerosisQ68126635
Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetesQ68636790
Cardiovascular risk factors in the elderlyQ69297978
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patientsQ69960611
Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitusQ70143635
Apolipoprotein E phenotypes in patients with myocardial infarctionQ71274632
NIDDM and its metabolic control predict coronary heart disease in elderly subjectsQ72080013
Apolipoprotein E and Alzheimer's diseaseQ72529552
Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitusQ72547648
Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterolQ72652935
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectheart diseaseQ190805
phenotypeQ104053
risk factorQ1475848
coronary artery diseaseQ844935
P304page(s)1280-1286
P577publication date1995-09-01
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleApolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects
Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects
P478volume15

Reverse relations

cites work (P2860)
Q40609823A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men.
Q48208048APOE does not predict poor outcome 1 year after ischemic stroke
Q53251385APOE genotype in cerebrovascular disease and vascular dementia.
Q44874657Age-dependent interaction of apolipoprotein E gene with eastern birthplace in Finland affects severity of coronary atherosclerosis and risk of fatal myocardial infarction--Helsinki Sudden Death Study
Q48430523Aging and cerebrovascular disease
Q40497278ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population
Q36804822ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation
Q35238425Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex
Q44009086Apolipoprotein E and longevity: the Rotterdam Study
Q48468088Apolipoprotein E and the CNS response to injury.
Q53251390Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.
Q36428621Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study
Q47732476Apolipoprotein E genotype in patients with cerebrovascular diseases and its effect on the disease outcome
Q38448974Apolipoprotein E genotypes and cognitive functions in healthy elderly persons
Q54701449Apolipoprotein E polymorphism and stroke in a population from eastern Turkey.
Q44300579Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort.
Q46665694Apolipoprotein E polymorphism is not a predictor for repeated coronary artery bypass surgery
Q34688023Apolipoproteins and aging: emerging mechanisms
Q48244141Association between apolipoprotein E4 and rehabilitation outcome in hospitalized ischemic stroke patients.
Q30588614Association between the apolipoprotein E gene polymorphism and ischemic stroke in Chinese populations: New data and meta-analysis
Q46521620Association of apolipoprotein E genotype and cerebrovascular disease risk factors in a Turkish population
Q46835614Association of apolipoprotein E genotype with early onset of coronary heart disease in Greek men.
Q80136825Association of apolipoprotein E polymorphism with ischemic stroke subtypes in Taiwan
Q50959234Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.
Q43906238Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes
Q34557702Candidate genes as potential links between periodontal and cardiovascular diseases
Q44111020Carotid artery intima-media thickness and brachial artery flow-mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes
Q73194210Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients
Q37768794Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors
Q47830369Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme
Q41725452Genetics of stroke--a review
Q44583853LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease
Q37389564Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States
Q53215966NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.
Q41707869Neurobiology of stroke.
Q37401949Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?
Q44457165Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study
Q41440536Prevention of primary event. Ischemic stroke risk detection and reduction.
Q35060418Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip
Q51568132Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study.
Q28601824Structural Neuroimaging Genetics Interactions in Alzheimer's Disease
Q24803218The Siblings With Ischemic Stroke Study (SWISS) protocol
Q44247540The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease
Q37364340The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology
Q33996158The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients
Q33950398The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models
Q73674062The role of apolipoprotein E in cognitive decline after cardiac operation
Q36698762The role of lipid-related genes, aging-related processes, and environment in healthspan

Search more.